HIND Share Price Performance
US$2.59
-11.41 (-81.50%)
Price US$2.59
Share Pricen/a
No recently updated narratives available.
Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Cambridge, Massachusetts.